China to Slash Prices of More than 400 Medicines for Respiratory Diseases
China will be slashing the prices of more than 400 types of medicine for respiratory diseases and for fever this February as part of the newest reform that started in the 2000 making health care cheap and more accessible. This will be the fourth price slash since 2011.
The National Development and Reform Commission said that the latest price cuts will involve 20 broad classes of medicines that are being used in the treatment of respiratory illnesses and fever. Specialty drugs will also be included in the price cuts. Average price cut will be at least 15 percent up to 20 percent for the expensive type of drugs. Earlier price cuts involved medicines such as anti biotic, hormonal and blood related medicines, anti tumor and drugs used in treating circulatory, digestive, nervous and immune systems.
In a press conference China’s health minister Chen Zhu said that health care in China is still expensive, and there is still and inadequate control in the improper use of drugs. And inflated drug prices and the irregularities in the production and distribution have also weakened the patients trust in doctors prescribing the medicines. These high prices increased the risks in the overdrafts in medical insurance funds which prompted a call for the tightening supervisions of doctor’s prescribing medication.
With an aging population China is slowly overhauling its health system since 2003, as of the moment the country has a basic universal medical insurance system that is heavily subsidized by a growing list of drugs